Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Diabetes Care
|
February 1, 1997
A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes
R E Maser, C Laudadio, M J Lenhard, et al.
Diabetes, Obesity & Metabolism
|
July 28, 2012
Direct renin inhibition improves parasympathetic function in diabetes
R E Maser, M J Lenhard, P Kolm, et al.
Diabetes Research and Clinical Practice
|
October 1, 1996
Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study
T J Orchard, C E LLoyd, R E Maser, et al.
Delaware Medical Journal
|
September 15, 1998
The new diagnosis and classification of diabetes mellitus
M J Lenhard, R E Maser, B C Patten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 13, 2003
Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study
Z Bosnyak, K Y-Z Forrest, R E Maser, et al.
Diabetes Care
|
May 1, 1995
A comparison between alternative and trade name glucose test strips
M J Lenhard, G S DeCherney, R E Maser, et al.
Diabetes
|
April 1, 1997
Hypertension as a risk factor for diabetic neuropathy: a prospective study
K Y Forrest, R E Maser, G Pambianco, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 1, 1992
Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus
P R Cavanagh, J A Derr, J S Ulbrecht, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 1, 1991
Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study
T J Orchard, R E Maser, D J Becker, et al.
Diabetes Care
|
May 1, 1993
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
R E Maser, D Usher, D J Becker, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Diabetes Care
|
February 1, 1997
A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes
R E Maser, C Laudadio, M J Lenhard, et al.
Diabetes, Obesity & Metabolism
|
July 28, 2012
Direct renin inhibition improves parasympathetic function in diabetes
R E Maser, M J Lenhard, P Kolm, et al.
Diabetes Research and Clinical Practice
|
October 1, 1996
Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study
T J Orchard, C E LLoyd, R E Maser, et al.
Delaware Medical Journal
|
September 15, 1998
The new diagnosis and classification of diabetes mellitus
M J Lenhard, R E Maser, B C Patten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 13, 2003
Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study
Z Bosnyak, K Y-Z Forrest, R E Maser, et al.
Diabetes Care
|
May 1, 1995
A comparison between alternative and trade name glucose test strips
M J Lenhard, G S DeCherney, R E Maser, et al.
Diabetes
|
April 1, 1997
Hypertension as a risk factor for diabetic neuropathy: a prospective study
K Y Forrest, R E Maser, G Pambianco, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 1, 1992
Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus
P R Cavanagh, J A Derr, J S Ulbrecht, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 1, 1991
Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study
T J Orchard, R E Maser, D J Becker, et al.
Diabetes Care
|
May 1, 1993
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
R E Maser, D Usher, D J Becker, et al.
Page
of 4